Related Experiment Videos
[Evaluation of medication side-effects from an economic perspective]
Omar Segura1, Carlos Maldonado
1Grupo de Farmacovigilancia, Instituto Nacional de Vigilancia de Medicamentos y Alimentos, INVIMA, Bogotá, D.C., Colombia. osmdmsc@tutopia.com
Biomedica : Revista Del Instituto Nacional De Salud
|February 19, 2004
Summary
Pharmacovigilance, the study of adverse drug reactions (ADR), requires better cost analysis. Implementing a national pharmacovigilance system in Colombia is crucial for managing these healthcare costs.
Area of Science:
- Health Sciences
- Pharmacology
- Health Economics
Context:
- Pharmacovigilance, focused on adverse drug reactions (ADR), has grown since the 1960s.
- Limited research exists on the decision-making costs associated with evaluating ADRs.
Purpose:
- To review the literature on costs incurred by managing adverse drug events in clinical practice.
- To estimate potential future ADR costs in Colombia by extrapolating international data.
- To highlight the necessity of a national pharmacovigilance system.
Summary:
- This review examines the financial implications of adverse drug reactions (ADRs) in healthcare.
- International data is used to project potential future ADR costs for Colombia.
- The study emphasizes the economic burden of ADRs and the need for a structured national pharmacovigilance system.
Impact:
- Raises awareness about the significant economic impact of adverse drug reactions.
- Provides a basis for cost-benefit analysis in pharmacovigilance system development.
- Advocates for the establishment of a national pharmacovigilance system to mitigate ADR-related costs and improve patient safety.